Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension
- PMID: 4357222
- PMCID: PMC1947200
Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension
Abstract
Labile hypertension is often associated with elevated cardiac output, increased plasma renin activity (PRA) and urinary cyclic AMP excretion in response to upright posture and to isoproterenol. The beta-blocking agent propranolol was demonstrated to be an effective therapeutic agent in this condition. The effect of posture on cyclic AMP, PRA, pulse rate and blood pressure was therefore studied during the administration of propranolol and a placebo in patients with labile hypertension. With the patient on placebo, upright posture induced an increase in pulse rate, cyclic AMP excretion and PRA. Propranolol administration decreased the recumbent and upright blood pressures, pulse rate and PRA. Cyclic AMP excretion remained unchanged in the recumbent position but the postural increase was abolished. No appreciable changes in catecholamine excretion occurred during propranolol administration. Propranolol normalizes some humoral as well as hemodynamic abnormalities of labile hypertension and therefore may be of benefit in long-term treatment and possibly also in the prevention of stable hypertension.
Similar articles
-
Plasma adenosine 3',5'-cyclic monophosphate in human hypertension.Can Med Assoc J. 1974 Aug 17;111(4):323-8. Can Med Assoc J. 1974. PMID: 4369018 Free PMC article. Clinical Trial.
-
[Treatment of essential hypertension with propranolol (author's transl)].Dtsch Med Wochenschr. 1976 Oct 8;101(41):1482-8. doi: 10.1055/s-0028-1104295. Dtsch Med Wochenschr. 1976. PMID: 183943 Clinical Trial. German.
-
Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.Acta Med Scand Suppl. 1973;550:1-40. Acta Med Scand Suppl. 1973. PMID: 4201751 Clinical Trial. No abstract available.
-
Labile (borderline) hypertension--new aspects of a common disorder.Angiology. 1975 Sep;26(8):619-31. doi: 10.1177/000331977502600805. Angiology. 1975. PMID: 233754 Review.
-
Haemodynamic effects of propranolol in hypertension: a review.Postgrad Med J. 1976;52 Suppl 4:92-100. Postgrad Med J. 1976. PMID: 787955 Review.
Cited by
-
Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.Klin Wochenschr. 1976 Nov 15;54(22):1095-105. doi: 10.1007/BF01469113. Klin Wochenschr. 1976. PMID: 1003867
-
Plasma adenosine 3',5'-cyclic monophosphate in human hypertension.Can Med Assoc J. 1974 Aug 17;111(4):323-8. Can Med Assoc J. 1974. PMID: 4369018 Free PMC article. Clinical Trial.
-
Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.Eur J Clin Pharmacol. 1975 Oct 10;9(1):9-19. doi: 10.1007/BF00613424. Eur J Clin Pharmacol. 1975. PMID: 9298
-
[Cyclic AMP and plasma renin activity in renal vein blood after amitryptiline, theophylline, furosemide and beta adrenergic blocking substances (author's transl)].Klin Wochenschr. 1976 Nov 15;54(22):1085-93. doi: 10.1007/BF01469112. Klin Wochenschr. 1976. PMID: 12404 German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials